The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.
Alba CorellSandra Ferreyra VegaNickoleta HoeflingLouise CarstamAnja SmitsThomas Olsson BontellIsabella M Björkman-BurtscherHelena CarénAsgeir Store JakolaPublished in: BMC cancer (2020)
The T2-FLAIR mismatch sign in patients with an IDH-mut astrocytoma is not associated with clinical presentation or outcome. It seems unlikely that the IDH-mut astrocytomas with mismatch sign represent a specific subentity. Finally, we have validated that the T2-FLAIR mismatch sign is a reliable and specific marker of IDH-mut astrocytomas.
Keyphrases